A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Merit Medical Systems, Inc. MMSI
Mixed broader-coverage candidate · Merit Medical Systems, Inc.
On FrontierLab's discovery record since 2026-06-29 (14 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-16), not the curated Frontier signal.
Key quality signals
| Revenue growth (YoY) | 10.3% |
|---|---|
| Gross margin | 49.5% |
| Gross profits / assets | 0.27 |
| Rule of 40 | 23.1 |
| Net margin | 12.8% |
| Cash runway (months) | — |
| PEG | 1.6 |
| Price / sales | 3.3 |
Quality checklist
- ~ Revenue growth — 10.3% (pass ≥ 20%)
- ~ Gross profits / assets — 0.27 (pass ≥ 0.33)
- ~ Gross margin — 49.5% (pass ≥ 60%)
- ✓ Cash generation
- ✓ Share dilution — -1%
Fundamentals — snapshot as of 2026-09-16
| Stage | Established |
|---|---|
| Share issuance (YoY) | -1% · flat share count |
| Moat | — |
| TAM | — |
| P/E (trailing) | 35.6 |
| EPS (trailing) | $2.42 |
| Burn multiple | — |
| Gross-margin trend (pts) | 1.6 |
| Cash / assets | 0.16 |
| Net debt / EBITDA | 1 |
| Statements as of | Q2 FY2026 · filed 2026-07-30 |
Momentum context — a snapshot from 2026-09-16, not current
| Price at surface | $86.18 (as of 2026-09-16) |
|---|---|
| 52-week range | $59.74 – $94.75 |
| % off 52-wk high | -9% |
| RSI (14) | 45 |
| Relative volume | 0.8× |
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-09-16 (end-of-day). How grades are computed →